Streamex Corp. (formerly BioSig Technologies, Inc.) completed a strategic acquisition of Streamex Exchange Corporation on May 28, 2025, shifting its primary business focus to tokenized asset finance and real-world asset (RWA) digitization. The company's legacy biomedical technology business, including the PURE EP platform and subsidiaries ViralClear Pharmaceuticals, Inc. and BioSig AI Sciences, Inc., is being evaluated for strategic alternatives, with ViralClear currently dormant and BioSig AI's operations on hold. For the fiscal year ended December 31, 2025, Streamex Corp. reported a net loss attributable to common stockholders of $462.8 million, significantly wider than the $10.5 million loss in 2024. This increased net loss was primarily driven by a non-cash loss of $389.7 million from the change in fair value of a derivative liability associated with Exchangeable Shares, and a $57.1 million increase in non-cash stock-based compensation expenses. Revenue for 2025 was $0, down from $40,000 in 2024, reflecting the shift away from the legacy medical device commercial activities. Research and development expenses decreased by 96% to $31,000 in 2025, as resources were reallocated to strategic transaction and integration activities. General and administrative expenses surged by 481% to $67.5 million in 2025, largely due to the aforementioned stock-based compensation and professional fees related to the Streamex Exchange acquisition. Post-year-end, in January and February 2026, the company significantly strengthened its liquidity by completing a public offering that generated $37.2 million in net proceeds, selling marketable securities for $10.1 million, and selling restricted gold assets for $26.4 million. The company also eliminated its outstanding secured debt by repaying $38.9 million in cash and converting $15.0 million of principal into 3,750,000 shares of common stock from its secured convertible debentures with Yorkville. The GLDY gold-backed digital token product was officially launched on February 25, 2026, and is actively accepting subscriptions from qualified investors.